bandera-espana1

 

 

Hall 1

8.15-8:30 Opening of the event
8:30-9:00 Acknowledgements
Plenary sessions   Moderador: Félix González
9:00-9:45 Epidemiology of Obesity, Diabetes and Cardiovascular DiseaseOscar Diaz Diaz,  M.D Cuba
9:45-10:30 Preventive Strategy of Overweight, Obesity and Diabetes, from Theory to Practice.Felix Escano, M.D  Dominican Republic
10:30-10:45  Coffee break

Hall  1

Hall 2

10:45-13:00 International Symposium
ALAD/CUBAModerators: Ileydis Iglesias y Ana ibis Conesa
Symposium
Integrated Management of Diabetic Foot Ulcers with Heberprot-P.Moderators: Eduardo Álvarez y Marisela Trasanco
10:45-11:10 Topicalities and controversies in gestational diabetes..Rafael M. Violante, M.D  Mexico Molecular Biology of Wound Cicatrization, the Contribution of the Recombinant Human Epidermal Growth Factor (EGF hrec)Jorge Berlanga, M.D  Cuba
11:10-11:35  Women with diabetes at reproductive phase and management of pregnancy planning. . Jacinto Lang, M.D  Cuba Heberprot-P Therapy Changes Paradigms in the Management of Diabetic Foot UlcersJosé Fernández Montequín, M.D Cuba
11:35-12:00 Comprehensive Care of the Child and the Adolescent with Diabetes Mellitus in CubaFrancisco Carvajal, M.D  Cuba Drug Surveillance of the Use of Heberprot-P Therapy in the Management of the Diabetic Foot Ulcers in CubaVerena Muzio, M.D  Cuba
12:00-12:25 Diabetes Mellitus in the Old Age, a New Health Problem?Emilio Bustillo, M.D  Cuba. Integrated Care Program for the Patient with Diabetic Foot Ulcers with the use of Heberprot-P. National and international Results and ProjectionsManuel Raíces, M.D Cuba
12:25-12:50 Diabetes/Prediabetes. TherapyJuan Rosas, M.D México. International Use of Heberprot-P and its Main Results and ProjectionsErnesto López Mola, M.D  Cuba
 13:00-14:30  Lunch
 14:30-15:00  Moderator: Francisco Gárciga Bionic Pancreas Technology for Type 1 Diabetes. . John Buse, Ph.D.  USA
 15:00-17:40 International Symposium
ALAD/CUBA
Moderators: Oscar Díaz Díaz and Arturo Hernández Yero
Lectures
Moderators: Emilio Buchaca y  Marisela Barceló
 15:00-15:30 Human Insuline in the Era of Analogues?  Manuel Vera, M.D.  Cuba. Some endoluminal procedures for obesity treatment.
José Hernández  M.D. Cuba
 15:30-16:00 Glyfozines: New Therapeutical Class in the Treatment of Type 2 Diabetes Mellitus.José A Mesa, M.D.  Mexico Reducing cardiovascular risk in type 2 diabetes: Issues and opportunities.
Jorge Plutzky, M.D.  USA
 16:00-16:30  Medical Inertia in the Diabetes ManagementFelix Escaño, M.D  Dominican Republic Intra-hospital Management of Diabetes.
Ariel Zisman, Ph.D.  USA
 16:30-17:00 Management of Hyperglycemia and Blood Hypertension in Hospitalized Patients with Cerebrovascular Disease.Manuel Licea, M.D.  Cuba Why oral health is crucial in diabetes management.
Wenche Borgnakke, Ph.D.  USA
17:00-17:30 Healthy Life Years Lost due to Diabetes in Cuba.Emma Dominguez  M.D.   Cuba ADA/EASD type 2 diabetes treatment recommendations.
John Buse, Ph.D.  USA

 

November 11th 
Hall 3

10:45-13:00 Lectures
Moderator: Julieta García
10:45-11:10 Changing epidemiology of type 1 diabetes.
Kendra Vehik, M.D.  USA
 11:10-11:35 Mapping the pathophysiological landscape of the diabetic human pancreas.
Dirk Homann, PhD..  USA
 11:35-12:00 Diabetes Drug Safety.John Buse,  Ph.D. USA
12:00-12:25 Hospital Treatment Protocol of Diabetes Mellitus, Basal-Bolus Therapy. Hospital de Mataró,Enrique Ballestar Mas  M.D.   Spain
12:25-12:50  Psychological wellbeing  and diabetes mellitus-associated vulnerabilities
Adriana Agramonte, Bachelor of Science, Cuba
13:00-14:30 Lunch
14:30-15:00 Moderator: José Fernández Montequín
The Cuban model for the prevention and treatment of the diabetic foot.
Orestes Faget, M.D.  Cuba